ITGB1 and cancer: Our previous studies showed that F806 suppresses cancer progression; though it downregulates the protein expression of actin cytoskeleton linkers ITGB1 and GRB2 [12, 13], proteins are involved in the formation of focal adhesions, which implies F806 can control dynamic changes of the cytoskeleton.